4.4 Article

Alteration of the coenzyme A biosynthetic pathway in neurodegeneration with brain iron accumulation syndromes

期刊

BIOCHEMICAL SOCIETY TRANSACTIONS
卷 42, 期 -, 页码 1069-1074

出版社

PORTLAND PRESS LTD
DOI: 10.1042/BST20140106

关键词

brain; coenzyme A (CoA); inborn error of metabolism; mitochondrion; neurodegeneration; pantothenate kinase 2 (PANK2)

资金

  1. Telethon [GGP11088]
  2. Mariani Foundation of Milan
  3. TIRCON project of the European Commission's Seventh Framework Programme (FP7), HEALTH-F2 [277984]

向作者/读者索取更多资源

NBIA (neurodegeneration with brain iron accumulation) comprises a heterogeneous group of neurodegenerative diseases having as a common denominator, iron overload in specific brain areas, mainly basal ganglia and globus pallidus. In the past decade a bunch of disease genes have been identified, but NBIA pathomechanisms are still not completely clear. PKAN (pantothenate kinase-associated neurodegeneration), an autosomal recessive disorder with progressive impairment of movement, vision and cognition, is the most common form of NBIA. It is caused by mutations in the PANK2 (pantothenate kinase 2) gene, coding for a mitochondrial enzyme that phosphorylates vitamin B-5 in the first reaction of the CoA (coenzyme A) biosynthetic pathway. A distinct form of NBIA, denominated CoPAN (CoA synthase protein-associated neurodegeneration), is caused by mutations in the CoASY (CoA synthase) gene coding for a bifunctional mitochondrial enzyme, which catalyses the final steps of CoA biosynthesis. These two inborn errors of CoA metabolism further support the concept that dysfunctions in CoA synthesis may play a crucial role in the pathogenesis of NBIA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据